Skip to Content
Merck
CN
  • The identification of potent and selective imidazole-based inhibitors of B-Raf kinase.

The identification of potent and selective imidazole-based inhibitors of B-Raf kinase.

Bioorganic & medicinal chemistry letters (2005-11-02)
Andrew K Takle, Murray J B Brown, Susannah Davies, David K Dean, Gerraint Francis, Alessandra Gaiba, Alex W Hird, Frank D King, Peter J Lovell, Antoinette Naylor, Alastair D Reith, Jon G Steadman, David M Wilson
ABSTRACT

A novel triarylimidazole derivative, SB-590885 (33), bearing a 2,3-dihydro-1H-inden-1-one oxime substituent has been identified as a potent and extremely selective inhibitor of B-Raf kinase.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
5-Bromo-1-indanone, 97%